Patient and public involvement: how much do we spend and what are the benefits?

被引:59
|
作者
Pizzo, Elena [1 ]
Doyle, Cathal [2 ]
Matthews, Rachel [3 ]
Barlow, James [4 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Sch Business, London SW7 2AZ, England
[2] Chelsea & Westminster Hosp NHS Fdn Trust, NIHR CLAHRC Northwest London, Evaluat, London, England
[3] Chelsea & Westminster Hosp NHS Fdn Trust, NIHR CLAHRC Northwest London, Patient & Publ Involvement, London, England
[4] Univ London Imperial Coll Sci Technol & Med, Sch Business, Technol & Innovat Management, London SW7 2AZ, England
关键词
benefits; costs; engagement; involvement; patient and public involvement; public; SHARED DECISION-MAKING; HEALTH-CARE; CONSUMER INVOLVEMENT; BREAST-CANCER; PARTICIPATION; IMPACT; POLICY; COSTS; STATE;
D O I
10.1111/hex.12204
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background and objectives Patient and public involvement (PPI) is seen as a way of helping to shape health policy and ensure a patient-focused health-care system. While evidence indicates that PPI can improve health-care decision making, it also consumes monetary and non-monetary resources. Given the financial climate, it is important to start thinking about the costs and benefits of PPI and how to evaluate it in economic terms. Design We conducted a literature review to assess the potential benefits and costs of involvement and the challenges in carrying out an economic evaluation of PPI. Results The benefits of PPI include effects on the design of new projects or services, on NHS governance, on research design and implementation and on citizenship and equity. Economic evaluation of PPI activities is limited. The lack of an appropriate analytical framework, data recording and understanding of the potential costs and benefits of PPI, especially from participants' perspectives, represent serious constraints on the full evaluation of PPI. Conclusions By recognizing the value of PPI, health-care providers and commissioners can embed it more effectively within their organizations. Better knowledge of costs may prompt organizations to effectively plan, execute, evaluate and target resources. This should increase the likelihood of more meaningful activity, avoid tokenism and enhance organizational efficiency and reputation.
引用
收藏
页码:1918 / 1926
页数:9
相关论文
共 50 条
  • [31] How much do we need experts during laparoscopic suturing training?
    Van Bruwaene, Siska
    De Win, Gunter
    Miserez, Marc
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2009, 23 (12): : 2755 - 2761
  • [32] How much CO2 emissions do we reduce by saving electricity? A focus on methods
    Harmsen, Robert
    Graus, Wina
    ENERGY POLICY, 2013, 60 : 803 - 812
  • [33] How do we trade off benefits and harms of anticancer drugs for advanced cancer patients?
    Kim, Do Yeun
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2023, 66 (02): : 86 - 90
  • [34] Patient and public involvement in research and the Cancer Experiences Collaborative: benefits and challenges
    Froggatt, Katherine
    Preston, Nancy
    Turner, Mary
    Kerr, Chris
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2015, 5 (05) : 518 - 521
  • [35] Economic burden of antibiotic resistance: how much do we really know?
    Gandra, S.
    Barter, D. M.
    Laxminarayan, R.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (10) : 973 - 980
  • [36] Productive effects of public works programs: What do we know? What should we know?
    Gehrke, Esther
    Hartwig, Renate
    WORLD DEVELOPMENT, 2018, 107 : 111 - 124
  • [37] Refugee Protection as a Public Good: What Benefits Do States Derive?
    Lutz, Philipp
    Caballero-Velez, Diego
    PERSPECTIVES ON POLITICS, 2024,
  • [38] Patient and public involvement in palliative care research: What works, and why? A qualitative evaluation
    Johnson, Halle
    Ogden, Margaret
    Brighton, Lisa Jane
    Etkind, Simon Noah
    Oluyase, Adejoke O.
    Chukwusa, Emeka
    Yu, Peihan
    de Wolf-Linder, Susanne
    Smith, Pam
    Bailey, Sylvia
    Koffman, Jonathan
    Evans, Catherine J.
    PALLIATIVE MEDICINE, 2021, 35 (01) : 151 - 160
  • [39] Transnational bureaucracies: How do we know what they know?
    Kuus, Merje
    PROGRESS IN HUMAN GEOGRAPHY, 2015, 39 (04) : 432 - 448
  • [40] Good Environmental Status of marine ecosystems: What is it and how do we know when we have attained it?
    Borja, Angel
    Elliott, Mike
    Andersen, Jesper H.
    Cardoso, Ana C.
    Carstensen, Jacob
    Ferreira, Joao G.
    Heiskanen, Anna-Stiina
    Marques, Joao C.
    Neto, Joao M.
    Teixeira, Heliana
    Uusitalo, Laura
    Uyarra, Maria C.
    Zampoukas, Nikolaos
    MARINE POLLUTION BULLETIN, 2013, 76 (1-2) : 16 - 27